In an Eμ-TCL1 mouse model of chronic lymphocytic leukemia, the incidence of leukemia is significantly lower in mice lacking Nfkb1, with CD19/CD5+ B cell numbers decreased despite no difference in overall survival. This evidence concerns the gene NFKB1 and B-cell chronic lymphocytic leukemia.